Evidence map›Paper›PMID 34924642›Full record

ReviewRevista brasileira de farmacognosia : orgao oficial da Sociedade Brasileira de Farmacognosia2021

Structural Diversity and Biological Potential of Alkaloids from the Genus

Luciana R Tallini, Raquel B Giordani, Jean Paulo de Andrade, Jaume Bastida, José Angelo S Zuanazzi

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Revista brasileira de farmacognosia : orgao oficial da Sociedade Brasileira de Farmacognosia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Potential Antiviral Compounds fromMolecules (Basel, Switzerland) · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Luciana R TalliniPrograma de Pós-graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS 90610-000 Brazil.ORCID 0000-0003-3890-0971
Raquel B GiordaniDepartamento de Farmácia, Universidade Federal do Rio Grande do Norte, Natal, RN 59012-570 Brazil.ORCID 0000-0001-6500-0755
Jean Paulo de AndradeInstituto de Investigación Interdisciplinaria, Vicerrectoría Académica, Universidad de Talca, Campus Talca, 3460000 Talca, Chile.ORCID 0000-0002-1680-5319
Jaume BastidaGrup de Productes Naturals, Departament de Biologia, Sanitat i Medi Ambient, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028 Barcelona, Spain.ORCID 0000-0002-0294-5927
José Angelo S ZuanazziPrograma de Pós-graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS 90610-000 Brazil.ORCID 0000-0003-1506-6355
Universidade Federal do Rio Grande do Sul · BRUniversidade Federal do Rio Grande do Norte · BRUniversitat de Barcelona · ESUniversity of Talca · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The subfamily Amaryllidoideae, Amaryllidaceae, presents an exclusive group of structures known as Amaryllidaceae alkaloids, which have a broad spectrum of biological activities. These plants are classified into 59 genera, including GRAPHICAL ABSTRACT: SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s43450-021-00211-z.

Indexed as

Alzheimer’s diseaseAnti-inflammatoryAntiparasiticAntitumoralCytotoxicIsoquinoline alkaloids

Identifiers

PMID34924642
PMCPMC8670614
OpenAlexW4200274845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.